Skip to main content

Complications of Cardiac Implantable Electronic Devices (CIED)

  • Chapter
  • First Online:
Cardiac Arrhythmias

Abstract

Complications of cardiac implantable electronic devices (CIED) are defined as any adverse event that requires either reintervention or additional diagnosis and therapeutic procedures. The complication rate of CIED devices ranges from 4 to 10 %, with a mortality under 0.1 %.

Acute phase and late complications can be related to venous access, lead positioning, and device pocket. There are common and specific complications depending on the electronic device type and the number and localization of the leads.

These complications are still a common problem, and the prevalence of some is increasing, since the implantation rate is increasing and also the complexity of the devices. Their economic impact is important as well as the consequences for the patients, that is why monitoring and treatment of these complications, insuring adequate training, and maintenance of competence should be part of the good clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Haug B, Kjelsberg K, Lappegård KT. Pacemaker implantation in small hospitals: complication rates comparable to larger centres. Europace. 2011;13:1580–6.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Ellenbogen KA, Wood MA. Cardiac pacing and ICDs. 5th ed. Hoboken: Wiley-Blackwell; 2008. p. 245–62.

    Google Scholar 

  3. Eberhardt F, Bode F, Bonnemeier H, et al. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart. 2005;91:500–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Peterson PN, Daugherty SL, Wang Y, et al. The National Data Registry. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119:1078–84.

    Article  PubMed  Google Scholar 

  5. Tobin K, Stewart J, Westveer D, et al. Acute complications of permanent pacemaker implantation: their financial implications and relation to volume and operator experience. Am J Cardiol. 2000;85:774–7.

    Article  CAS  PubMed  Google Scholar 

  6. Link MS, Estes 3rd NA, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. J Interv Card Electrophysiol. 1998;2:175–9.

    Article  CAS  PubMed  Google Scholar 

  7. Møller M, Arnsbo P, Asklund M, Christensen PD, Gadsbøll N, Svendsen JH, et al. Quality assessment of pacemaker implantations in Denmark. Europace. 2002;4:107–12.

    Article  PubMed  Google Scholar 

  8. Nowak B, Misselwitz B, Erdogan A, Funck R, Irnich W, Israel C, et al. Do gender differences exist in pacemaker implantation? Results of an obligatory external quality control program. Europace. 2010;12:152–3.

    Article  Google Scholar 

  9. Ellery SM, Paul VE. Complications of biventricular pacing. Eur Heart J Suppl. 2004;6(Suppl D):D117–21.

    Article  Google Scholar 

  10. Reinolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493–7.

    Article  Google Scholar 

  11. Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail. 2000;6(4):369–80.

    Article  CAS  PubMed  Google Scholar 

  12. Luck JC, Wolbrette DL, Boehmer JP, et al. Biventricular pacing in congestive heart failure: a boost toward finer living. Curr Opin Cardiol. 2002;17(1):96–101.

    Article  PubMed  Google Scholar 

  13. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter- defibrillators: results of a large prospective study. Circulation. 2007;116:1349–55.

    Article  PubMed  Google Scholar 

  14. Pakarinen S, Oikarinen L, Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. Europace. 2010;12:103–8.

    Article  PubMed  Google Scholar 

  15. Pescariu S. Implantul de stimulator cardiac. Timisoara: Brumar; 1996. p. 136–51.

    Google Scholar 

  16. Pescariu S. Aritmii. Ghid clinic. Timisoara: Brumar; 2004. p. 170–2.

    Google Scholar 

  17. Timperley J, Leeson P, Mitchell ARJ, et al. Pacemakers and ICDs. Oxford: Oxford University Press; 2008. p. 84–93.

    Google Scholar 

  18. Molnár L, Szucs G, Zima E, et al. Successful management and long term outcome of an accidental subclavian artery injury with a 9 French dilator during pacemaker implantation with collagen-based closure device. J Interv Card Electrophysiol. 2009;25(3):217–8.

    Article  PubMed  Google Scholar 

  19. Meyhoefer J, Lehmann H, Minden HH, et al. Closure of the subclavian artery puncture site with a percutaneous suture device after removal of an arterial pacemaker lead. Europace. 2006;8(12):1070–2.

    Article  PubMed  Google Scholar 

  20. Libby P, Bonow RO, Zipes DP, Mann DL. Pacemakers and implantable cardioverter-defibrillators. In: Braunwald’s heart disease, A textbook of cardiovascular medicine. 9th ed. Philadelphia: Elsevier Saunders; 2012. p. 162.

    Google Scholar 

  21. Villalba S, Roda J, Quesada A, et al. Retrospective study of patients who undergo pacemaker implantation in short-stay ambulatory surgery. Long-term follow-up and cost analysis. Rev Esp Cardiol. 2004;57(3):234–40.

    PubMed  Google Scholar 

  22. Sadamatsu K. Complication of pacemaker implantation: an atrial lead perforation. In: Das MR, editor. Modern pacemakers – present and future. Rijeka: InTech; 2011. doi: 10.5772/13854. ISBN: 978-953-307-214-2.

    Google Scholar 

  23. Al Ahmad A, Ellenbogen KA, Natale A, et al. Pacemakers and implantable cardioverter defibrillators. An expert’s manual. Minneapolis: Cardiotext Publishing; 2010. p. 39–43.

    Google Scholar 

  24. Ellenbogen KA, Wood MA, Shepard RK, et al. Detection and management of an implantable cardioverter lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73–80.

    Article  PubMed  Google Scholar 

  25. Ritter F, Fischer W. Pratique de la Stimulation Cardiaque. Paris: Springer; 1997. p. 225–50.

    Google Scholar 

  26. Rozmus G, Daubert JP, Huang DT, et al. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol. 2005;13:9–19.

    Article  PubMed  Google Scholar 

  27. Wiegand UKH, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest. 2004;126:1177–86.

    Article  PubMed  Google Scholar 

  28. Van Eck JWM, Van Hemel NM, Zuithof P, et al. Incidence and predictors of in-hospital events after first implantation of pacemakers. Europace. 2007;9:884–9.

    Article  PubMed  Google Scholar 

  29. Dhua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604–8.

    Article  Google Scholar 

  30. Uslan DZ, Gleva MJ, Warren DK, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin Electrophysiol. 2012;35:81–7.

    Article  PubMed  Google Scholar 

  31. Greenspon AJ, Patel JD, Lau E, et al. 16 year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coli Cardiol. 2011;58:1001–6.

    Article  Google Scholar 

  32. Yu CM, Hayes DL, Auricchio A. Cardiac resynchronization therapy. London: Blackwell Futura; 2008. p. 214–31.

    Book  Google Scholar 

  33. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873–80.

    Article  CAS  PubMed  Google Scholar 

  34. Hellerstein HK, Orbison JL. Anatomic variations of the orifice of the human coronary sinus. Circulation. 1951;3:514–23.

    Article  CAS  PubMed  Google Scholar 

  35. Alonso C, Leclercq C, Revault d’Allonnes F, et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart. 2001;86:405–10.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Lenarczyk R, Kowalski O, Kukulski T, et al. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study. Europace. 2007;9:762–7.

    Article  PubMed  Google Scholar 

  37. Kowalski O, Lanarczyk R, Prokopczuk J, et al. Effect of percutaneous interventions within the coronary sinus on the success rate of the implantations of resynchronization pacemakers. Pacing Clin Electrophysiol. 2006;29:1075–80.

    Article  PubMed  Google Scholar 

  38. De Cock CC, van Campen CM, Visser CA. Major dissection of the coronary sinus and its tributaries during lead implantation for biventricular stimulation: angiographic follow up. Europace. 2004;6:43–7.

    Article  PubMed  Google Scholar 

  39. Mela T, Ngarmukos T, Rosenthal L, et al. Inappropriate ICD therapy due to lead- related noise in an active fixation ICD lead. J Invasive Cardiol. 2001;13(5):406–8.

    CAS  PubMed  Google Scholar 

  40. Bayliss CE, Beanlands DS, Baird RJ. The pacemaker-twiddler’s syndrome: a new complication of implantable transvenous pacemakers. Can Med Assoc J. 1968;99(8):371.

    CAS  PubMed Central  PubMed  Google Scholar 

  41. Nery PB, Fernandes R, Nair GM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010;21:786–90.

    PubMed  Google Scholar 

  42. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369–413.

    Article  PubMed  Google Scholar 

  43. Chua JD, Wilkoff BL, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604–8.

    Article  CAS  PubMed  Google Scholar 

  44. Sohail MR, Uslan DZ, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46–53.

    Article  PubMed  Google Scholar 

  45. Ruttman E, Hangler HB, et al. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol. 2006;29(3):231–6.

    Article  Google Scholar 

  46. Knight BP, Desai A, Coman J, et al. Long- term retention of cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:72–7.

    Article  PubMed  Google Scholar 

  47. Leon AR, Abraham WT, Curtis AB et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2000 patients from a multicenter study program (MIRACLE study program). J Am Coll Cardiol. 2005;46:2348–56.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sorin Pescariu MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Pescariu, S., Sosdean, R. (2014). Complications of Cardiac Implantable Electronic Devices (CIED). In: Kibos, A., Knight, B., Essebag, V., Fishberger, S., Slevin, M., Țintoiu, I. (eds) Cardiac Arrhythmias. Springer, London. https://doi.org/10.1007/978-1-4471-5316-0_51

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5316-0_51

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5315-3

  • Online ISBN: 978-1-4471-5316-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics